Modeled Oxidative Lesions Remodel the ABCB1 Linker: A Hypothesis for Transporter Regulation

Authors

Hoseini, M., Abbasi, H.

Abstract

Multidrug resistance mediated by P-glycoprotein (P-gp; ABCB1) remains a major barrier to chemotherapy. Cold atmospheric plasma (CAP) has increased drug responsiveness in resistant cancer models, but the molecular link between plasma-derived oxidative chemistry and ABCB1 regulation remains unresolved. We investigated whether site-specific oxidative lesions remodel the intrinsically disordered linker connecting nucleotide-binding domain 1 to transmembrane domain 2. Native-ensemble exposure analysis identified contrasting oxidation candidates: dynamically exposed Met653 and persistently exposed Trp698. Met653 oxidation to methionine sulfoxide and Trp698 oxidation to kynurenine were examined individually and together using a balanced 2 by 2 molecular-dynamics design with a mechanically tethered linker construct. Analyses integrated global descriptors, residue-resolved mobility, backbone order, native-state occupancies, projected breadth, and conformational switching. Trp698[->]KYN produced the dominant response: all seven global descriptors shifted toward restriction, accompanied by distributed mobility changes, compaction, and increased intramolecular hydrogen bonding. In the radius-of-gyration/end-to-end-distance projection, compact-state occupancy increased from 46.9% to 99.7%, switching decreased from 6.50 to 0.07 transitions per 10 ns, and projected breadth contracted. Met653[->]SME produced weaker, heterogeneous effects, while the double-modified linker remained restricted but showed greater projected exchange than Trp698[->]KYN alone. In this model, Trp698[->]KYN generated a compact, low-exchange projected ensemble in the tethered ABCB1 linker. These findings identify oxidation-site-specific linker remodeling as a candidate molecular intermediate that could influence linker-mediated domain coordination, while requiring experimental validation of lesion formation, transporter activity, and multidrug resistance outcomes.

Preprint server: bioRxiv
The authors list and abstract were imported from bioRxiv on 17 Oct 2026.

Stats

1-terrible, 9-excellent. How would you rate this preprint? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.